查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423953

狗疫苗市场、份额、规模、趋势、行业分析报告：按疫苗类型、按疾病类型、按给药途径、按免疫持续时间、按成分、按地区、按细分市场预测，2024-2032 年

Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球狗疫苗市场规模将达到27.0828亿美元。 该报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于宠物健康和更广泛的兽药行业日益重要的综合因素，犬疫苗市场近年来经历了显着增长。 这一市场扩张背后的驱动力之一是狗主人越来越意识到接种疫苗预防狗的各种疾病的好处。 随着越来越多的人意识到与犬类疾病相关的潜在风险，对有效疫苗的需求不断增长，以保护他们心爱的宠物免受这些健康威胁。

此外，兽医研究和技术的进步正在促进功效和安全性更高的创新疫苗的开发。 这不仅扩大了可预防疾病的范围，也提高了犬类医疗照护的整体品质。 兽医专业人员比以往任何时候都更有能力提供量身定制的疫苗接种方案，以满足每隻狗的独特需求，同时考虑到年龄、品种和生活方式等因素。我们已做好准备。

此外，监管措施和公共卫生运动在塑造狗疫苗市场的动态方面发挥关键作用。 世界各地的政府机构和兽医协会积极倡导负责任的宠物饲养，并强调定期接种疫苗作为预防性医疗保健基石的重要性。 这些共同努力为兽用疫苗领域的研发创造了更有利的监管环境并增加了公共资金。

此外，宠物人性化的趋势进一步推动了对先进医疗解决方案（包括疫苗）的需求，以确保狗的福祉和长寿。 宠物主人越来越多地将他们的狗视为家庭的重要成员，因此愿意投资预防措施来帮助他们的狗过上更健康的生活。 这种将宠物视为家庭成员的文化转变为疫苗製造商创造了利润丰厚的市场机会，并培育了以不断创新和产品开发为特征的竞争格局。

狗疫苗市场报告亮点

减毒疫苗在市场上占据主导地位，因为它有助于预防疾病并提供长期免疫力

狂犬病预计将快速增长，主要是因为其高盛行率和人畜共患病的可能性。

由于宠物数量众多以及宠物主人意识的不断增强，亚太地区将以最快的速度增长。

目录

第一章简介

  • 报告说明
    • 研究目的
    • 市场范围
    • 假设
  • 利害关係人

第 2 章执行摘要

第3章研究方法

第4章全球狗疫苗市场洞察

  • 犬疫苗市场－免疫期概况
  • 犬隻疫苗市场动态
    • 推动者和机会
      • 养宠物的现像日益普遍
      • 兽医学的进展
    • 抑制因素和挑战
      • 疫苗成本高
  • PESTEL 分析
  • 犬疫苗市场免疫期趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第5章全球狗疫苗市场（依疾病类型）

  • 主要发现
  • 简介
  • 犬瘟热
  • 犬传染性呼吸道疾病综合体 (CIRDC)
  • 犬小病毒病/小病毒病
  • 犬钩端螺旋体病
  • 狗的莱姆病
  • 犬传染性肝炎
  • 狂犬病
  • 其他

第 6 章全球狗疫苗市场（依疫苗类型）

  • 主要发现
  • 简介
  • 退化/寿命减弱
  • 失活（失活）
  • 其他

第7章全球狗疫苗市场，依免疫期划分

  • 主要发现
  • 简介
  • 1 年
  • 3年
  • 其他

第 8 章全球狗疫苗市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年犬隻疫苗市场评估（按地区）
  • 狗疫苗市场 - 北美
    • 北美：狗疫苗市场，依疾病类型，2019-2032 年
    • 北美：狗疫苗市场，依免疫期划分，2019-2032 年
    • 北美：狗疫苗市场，依疫苗类型，2019-2032 年
    • 狗狗疫苗市场 - 美国
    • 狗疫苗市场 - 加拿大
  • 犬疫苗市场 - 欧洲
    • 欧洲：2019-2032 年按疾病类型划分的狗疫苗市场
    • 欧洲：狗疫苗市场，依免疫期划分，2019-2032 年
    • 欧洲：2019-2032 年狗狗疫苗市场（以疫苗类型）
    • 狗狗疫苗市场 - 英国
    • 犬疫苗市场 - 法国
    • 狗狗疫苗市场 - 德国
    • 狗疫苗市场 - 义大利
    • 狗狗疫苗市场 - 西班牙
    • 犬疫苗市场 - 荷兰
    • 狗狗疫苗市场 - 俄罗斯
  • 犬疫苗市场 - 亚太地区
    • 亚太地区：狗疫苗市场，依疾病类型，2019-2032 年
    • 亚太地区：狗疫苗市场，依免疫期划分，2019-2032 年
    • 亚太地区：狗疫苗市场，依疫苗类型，2019-2032 年
    • 狗狗疫苗市场 - 中国
    • 犬疫苗市场 - 印度
    • 犬疫苗市场 - 马来西亚
    • 狗狗疫苗市场 - 日本
    • 犬疫苗市场 - 印度尼西亚
    • 犬疫苗市场－韩国
  • 狗狗疫苗市场 - 中东和非洲
    • 中东和非洲：2019-2032 年狗疫苗市场（按疾病类型）
    • 中东和非洲：狗疫苗市场，按免疫期划分，2019-2032 年
    • 中东和非洲：2019-2032 年狗疫苗市场（按疫苗类型）
    • 犬疫苗市场－沙乌地阿拉伯
    • 犬疫苗市场 - 阿拉伯联合大公国
    • 狗狗疫苗市场 - 以色列
    • 狗疫苗市场 - 南非
  • 犬疫苗市场 - 拉丁美洲
    • 拉丁美洲：狗疫苗市场，依疾病类型划分，2019-2032 年
    • 拉丁美洲：狗疫苗市场，按免疫期划分的狗疫苗市场，2019-2032 年
    • 拉丁美洲：2019-2032 年狗疫苗市场（以疫苗类型）
    • 狗狗疫苗市场 - 墨西哥
    • 狗狗疫苗市场 - 巴西
    • 犬疫苗市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Bioveta a.s
  • .Hester Biosciences Limited
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac
  • Zendal Group
  • Elanco
  • Zoetis Services
Product Code: PM4185

The global dog vaccine market size is expected to reach USD 2,708.28 million by 2032, according to a new study by Polaris Market Research. The report "Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dog vaccine market has experienced significant growth in recent years, driven by a combination of factors that underscore the increasing importance of pet health and the broader veterinary pharmaceutical industry. One of the primary driving forces behind this expansion is the rising awareness among pet owners about the benefits of vaccination in preventing various diseases in dogs. As more individuals become informed about the potential risks associated with canine illnesses, there is a heightened demand for effective vaccines that can safeguard their beloved pets from these health threats.

Furthermore, advancements in veterinary research and technology have facilitated the development of innovative vaccines with improved efficacy and safety profiles. This has not only expanded the range of diseases that can be prevented but also enhanced the overall quality of canine healthcare. Veterinary professionals are now better equipped than ever to provide tailored vaccination protocols that address the unique needs of individual dogs, considering factors such as age, breed, and lifestyle.

Additionally, regulatory initiatives and public health campaigns have played a pivotal role in shaping the dynamics of the dog vaccine market. Governmental organizations and veterinary associations across the globe have been actively promoting responsible pet ownership and emphasizing the importance of regular vaccinations as a cornerstone of preventive healthcare. These concerted efforts have contributed to a more favorable regulatory environment and increased public funding for research and development in the veterinary vaccine sector.

Moreover, the growing trend of humanization of pets has further propelled the demand for advanced healthcare solutions, including vaccines, to ensure the well-being and longevity of dogs. Pet owners are increasingly viewing their canine companions as integral members of their families and are therefore willing to invest in preventive measures that can help them lead healthier lives. This cultural shift towards treating pets as family members has created a lucrative market opportunity for vaccine manufacturers and has fostered a competitive landscape characterized by continuous innovation and product development.

Dog Vaccine Market Report Highlights

Attenuated vaccine segment dominated the market, as it helps in preventing disease and provides long term immunity

Canine rabies segment will grow at the rapid pace, primarily due to its high prevalence rate, and its zoonotic potential

APAC to grow at the fastest rate, owing to the presence of large number of pets in the region and growing awareness among pet owners

The global players include Bioveta, Hester Biosciences, Boehringer Ingelheim, Brilliant Bio Pharma, Heska Corp., Merck, Virbac, Elanco, and Zoetis Services

Polaris Market Research has segmented the dog vaccine market report based on vaccine type, disease type, duration of immunity, and region:

Dog Vaccine, Vaccine Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others

Dog Vaccine, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Canine Distemper
  • Canine Infectious Respiratory Disease Complex (CIRDC)
  • Canine Parvovirosis/ Parvovirus Disease
  • Canine Leptospirosis
  • Canine Lyme Disease
  • Infectious Canine Hepatitis
  • Canine Rabies
  • Others

Dog Vaccine, Duration of Immunity Outlook (Revenue - USD Million, 2019 - 2032)

  • 1-Year
  • 3-Year
  • Others

Dog Vaccine, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dog Vaccine Market Insights

  • 4.1. Dog Vaccine Market - Duration of Immunity Snapshot
  • 4.2. Dog Vaccine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Pet Adoption Rates
      • 4.2.1.2. Advancements in Veterinary Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Vaccines
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dog Vaccine Market Duration of Immunity Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dog Vaccine Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • 5.3. Canine Distemper
    • 5.3.1. Global Dog Vaccine Market, by Canine Distemper, by Region, 2019-2032 (USD Million)
  • 5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
    • 5.4.1. Global Dog Vaccine Market, by Canine Infectious Respiratory Disease Complex (CIRDC), by Region, 2019-2032 (USD Million)
  • 5.5. Canine Parvovirosis/ Parvovirus Disease
    • 5.5.1. Global Dog Vaccine Market, by Canine Parvovirosis/ Parvovirus Disease, by Region, 2019-2032 (USD Million)
  • 5.6. Canine Leptospirosis
    • 5.6.1. Global Dog Vaccine Market, by Canine Leptospirosis, by Region, 2019-2032 (USD Million)
  • 5.7. Canine Lyme Disease
    • 5.7.1. Global Dog Vaccine Market, by Canine Lyme Disease, by Region, 2019-2032 (USD Million)
  • 5.8. Infectious Canine Hepatitis
    • 5.8.1. Global Dog Vaccine Market, by Infectious Canine Hepatitis, by Region, 2019-2032 (USD Million)
  • 5.9. Canine Rabies
    • 5.9.1. Global Dog Vaccine Market, by Canine Rabies, by Region, 2019-2032 (USD Million)
  • 5.10. Others
    • 5.10.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Dog Vaccine Market, by Vaccine Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 6.3. Modified/ Attenuated Live
    • 6.3.1. Global Dog Vaccine Market, by Modified/ Attenuated Live, by Region, 2019-2032 (USD Million)
  • 6.4. Inactivated (Killed)
    • 6.4.1. Global Dog Vaccine Market, by Inactivated (Killed), by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Dog Vaccine Market, by Duration of Immunity

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • 7.3. 1-Year
    • 7.3.1. Global Dog Vaccine Market, by 1-Year, By Region, 2019-2032 (USD Million)
  • 7.4. 3-Year
    • 7.4.1. Global Dog Vaccine Market, by 3-Year, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Dog Vaccine Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Dog Vaccine Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Dog Vaccine Market - North America
    • 8.3.1. North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.3.3. North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.3.4. Dog Vaccine Market - U.S.
      • 8.3.4.1. U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.3.5. Dog Vaccine Market - Canada
      • 8.3.5.1. Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.4. Dog Vaccine Market - Europe
    • 8.4.1. Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.4.3. Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.4. Dog Vaccine Market - UK
      • 8.4.4.1. UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.5. Dog Vaccine Market - France
      • 8.4.5.1. France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.5.3. France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.6. Dog Vaccine Market - Germany
      • 8.4.6.1. Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.7. Dog Vaccine Market - Italy
      • 8.4.7.1. Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.8. Dog Vaccine Market - Spain
      • 8.4.8.1. Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.9. Dog Vaccine Market - Netherlands
      • 8.4.9.1. Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.10. Dog Vaccine Market - Russia
      • 8.4.10.1. Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.5. Dog Vaccine Market - Asia Pacific
    • 8.5.1. Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.4. Dog Vaccine Market - China
      • 8.5.4.1. China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.4.3. China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.5. Dog Vaccine Market - India
      • 8.5.5.1. India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.5.3. India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.6. Dog Vaccine Market - Malaysia
      • 8.5.6.1. Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.7. Dog Vaccine Market - Japan
      • 8.5.7.1. Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.8. Dog Vaccine Market - Indonesia
      • 8.5.8.1. Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.9. Dog Vaccine Market - South Korea
      • 8.5.9.1. South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.6. Dog Vaccine Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.4. Dog Vaccine Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.5. Dog Vaccine Market - UAE
      • 8.6.5.1. UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.6. Dog Vaccine Market - Israel
      • 8.6.6.1. Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.7. Dog Vaccine Market - South Africa
      • 8.6.7.1. South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.7. Dog Vaccine Market - Latin America
    • 8.7.1. Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.4. Dog Vaccine Market - Mexico
      • 8.7.4.1. Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.5. Dog Vaccine Market - Brazil
      • 8.7.5.1. Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.6. Dog Vaccine Market - Argentina
      • 8.7.6.1. Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bioveta a.s
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Hester Biosciences Limited
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim International GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Brilliant Bio Pharma
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Heska Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck & Co., Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Virbac
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Zendal Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Elanco
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Zoetis Services
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 2 Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 3 Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 4 Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 6 North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 7 North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 8 U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 11 Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 12 Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 13 Canada: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 14 Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 15 Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 16 Europe: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 17 UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 18 UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 19 UK: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 20 France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 21 France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 22 France: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 23 Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 24 Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 25 Germany: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 26 Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 27 Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 28 Italy: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 29 Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 30 Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 31 Spain: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 32 Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 35 Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 36 Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 37 Russia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 41 China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 42 China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 43 China: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 44 India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 45 India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 46 India: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 47 Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 50 Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 51 Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 52 Japan: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 53 Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 56 South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 65 UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 66 UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 67 UAE: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 68 Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 69 Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 70 Israel: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 71 South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 74 Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 77 Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 80 Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 83 Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Dog Vaccine Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Vaccine Type
  • Figure 7. Global Dog Vaccine Market, by Vaccine Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Disease Type
  • Figure 9. Global Dog Vaccine Market, by Disease Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by Duration of Immunity
  • Figure 11. Global Dog Vaccine Market, by Duration of Immunity, 2022 & 2032 (USD Million)
  • Figure 12. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Dog Vaccine Market